PET assessment of disease activity in children with juvenile idiopathic arthritis

Pediatric Radiology

Volumn 40, Issue 11, 2010, Pages 1781-1788

  Tateishi, Ukihide ^a   Imagawa, Tomoyuki ^b   Kanezawa, Noriko ^a   Okabe, Tetsuhiko ^a   Shizukuishi, Kazuya ^a   Inoue, Tomio ^a   Yokota, Shumpei ^b  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Child; Disease activity; Juvenile idiopathic arthritis; PET

Indexed keywords

C REACTIVE PROTEIN; CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; FLUORODEOXYGLUCOSE F 18; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; STROMELYSIN; TOCILIZUMAB;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; JOINT SWELLING; JUVENILE RHEUMATOID ARTHRITIS; MALE; NEUTROPHIL COUNT; POSITRON EMISSION TOMOGRAPHY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD; TREATMENT RESPONSE; WHOLE BODY PET;

ADOLESCENT; ARTHRITIS, JUVENILE RHEUMATOID; CHILD; CHILD, PRESCHOOL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; INFANT; MALE; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SYNOVIAL MEMBRANE;

EID: 78650190641     PISSN: 03010449     EISSN: 14321998     Source Type: Journal    
DOI: 10.1007/s00247-010-1716-5     Document Type: Article

References (25)

1. Ravelli A, Martini A (2007) Juvenile idiopathic arthritis. Lancet 369:767-778
2. Petty RE, Southwood TR, Manners P et al (2004) International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: Second revision, Edmonton, 2001. J Rheumatol 31:390-392
3. Lovell DJ, Giannini EH, Reiff A et al (2000) Etarercept in children with polyarticular rheumatoid arthritis. Paediatric Rheumatology Collaborative Study Group. N Engl J Med 342:763-769
4. Russo RA, Katsicas MM, Zalazko M (2002) Etanercept in systemic juvenile idiopathic arthritis. Clin Exp Rheumatol 20:723-726
5. Quartier P, Taupin P, Bourdeaut F et al (2003) Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type. Arthritis Rheum 48:1093-1101
6. Gerloni V, Pontikaki I, Gattinara M et al (2005) Efficacy of repeated intravenous infusions of an anti-tumor necrosis factor alpha monoclonal antibody, infliximab, in persistently active, refractory juvenile idiopathic arthritis: Results of an open-label prospective study. Arthritis Rheum 52:548-553
7. Katsicas MM, Russo RA (2005) Use of infliximab in patients with systemic juvenile idiopathic arthritis refractory to etanercept. Clin Exp Rheumatol 23:545-548
8. Yokota S, Imagawa T, Miyamae T et al (2004) Long-term therapeutic experience of humanized anti-IL-6 receptor monoclonal antibody (aIL-6R Mab) in systemic-onset juvenile idiopathic arthritis (So-JIA). Arthritis Rheum 50:S438
9. Yokota S, Miyamae T, Imagawa T et al (2005) Clinical study of tocilizumab in children with systemic-onset juvenile idiopathic arthritis. Clin Rev Allergy Immunol 28:231-238
10. Yokota S, Imagawa T, Mori M et al (2008) Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: A randomized, double-blind, placebo-controlled, withdrawal phase II trial. Lancet 371:998-1006
11. Reed MH, Wilmot DM (1991) The radiology of juvenile rheumatoid arthritis. A review of the English language literature. J Rheumatol Suppl 31:2-22
12. Rossi F, Di Dia F, Galipo O et al (2006) Use of Sharp and Larsen scoring methods in the assessment of radiographic progression in juvenile idiopathic arthritis. Arthritis Rheum 55:717-723
13. Doria AS, Babyn P, Feldman B (2006) A critical appraisal of radiographic scoring systems for assessment of juvenile idiopathic arthritis. Pediatr Radiol 36:759-772
14. Malattia C, Damasio MB, Magnaguagno F et al (2008) Magnetic resonance imaging, ultrasonography, and conventional radiography in the assessment of bone erosions in juvenile idiopathic arthritis. Arthritis Rheum 59:1764-1772
15. Pedersen TK, Kuseler A, Gelineck J et al (2008) A prospective study of magnetic resonance and radiographic imaging in relation to symptoms and clinical findings of the temporomandibular joint in children with juvenile idiopathic arthritis. J Rheumatol 35:1668-1675
16. Wipke BT, Wang Z, Kim J et al (2002) Dynamic visualization of joint specific autoimmune response through positron emission tomography. Nat Immunol 3:366-372
17. Fonseca A, Wagner J, Yamaga LI et al (2008) (18) F-FDG PET imaging of rheumatoid articular and extraarticular synovitis. J Clin Rheumatol 14:307
18. Beckers C, Ribbens C, André B et al (2004) Assessment of disease activity in rheumatoid arthritis with (18)F-FDG PET. J Nucl Med 45:956-964
19. Giannini EH, Ruperto N, Ravelli A et al (1997) Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 40:1202-1209
20. Polisson RP, Schoenberg OI, Fischman A et al (1995) Use of magnetic resonance imaging and positron emission tomography in the assessment of synovial volume and glucose metabolism in patients with rheumatoid arthritis. Arthritis Rheum 38:819-825
21. Goerres GW, Forster A, Uebelhart D et al (2006) F-18 FDG whole-body PET for the assessment of disease activity in patients with rheumatoid arthritis. Clin Nucl Med 31:386-390
22. Elzinga EH, van der Laken CJ, Comans EF et al (2007) 2-Deoxy-2-[F-18] fluoro-D-glucose joint uptake on positron emission tomography images: Rheumatoid arthritis versus osteoarthritis. Mol Imaging Biol 9:357-360
23. Beckers C, Jeukens X, Ribbens C et al (2006) (18)F-FDG PET imaging of rheumatoid knee synovitis correlates with dynamic magnetic resonance and sonographic assessments as well as with the serum level of metalloproteinase-3. Eur J Nucl Med Mol Imaging 33:275-280
24. Ju JH, Kang KY, Kim IJ et al (2008) Visualization and localization of rheumatoid knee synovitis with FDG-PET/CT images. Clin Rheumatol 27:S39-S41
25. Roivainen A, Parkkola R, Yli-Kerttula T et al (2003) Use of positron emission tomography with methyl-11C-choline and 2-18F-fluoro-2-deoxy-D-glucose in comparison with magnetic resonance imaging for the assessment of inflammatory proliferation of synovium. Arthritis Rheum 48:3077-3084